Get started
Author

Anlin Hao

Observed names: An-Lin Hao, An-lin Hao
ORCID: 0000-0001-7450-6467
Observed ORCID: 0000-0001-7450-6467
OpenAlex ID: A5060794030
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial
2024 · Jianjun Qin, Liyan Xue, et al. · Nature Medicine · 282
NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway
2019 · Yaowen Zhang, Anping Zheng, et al. · Biochemical and Biophysical Research Communications · 34
Chemotherapy plus camrelizumab versus chemotherapy alone as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (ESCORT-NEO): A multi-center, randomized phase III trial.
2024 · Yin Li, Jianjun Qin, et al. · Journal of Clinical Oncology · 17
PDF
Diagnosis of Esophageal Squamous Cell Carcinoma by High‐Performance Serum Metabolic Fingerprints: A Retrospective Study
2023 · Yida Huang, Haijun Yang, et al. · Small Methods · 15
PDF
Minimally invasive versus open esophagectomy for resectable thoracic esophageal cancer (NST 1502): a multicenter prospective cohort study
2023 · Yousheng Mao, Shugeng Gao, et al. · Journal of the National Cancer Center · 13
Mirror siRNAs loading for dual delivery of doxorubicin and autophagy regulation siRNA for multidrug reversing chemotherapy
2020 · Bo Yang, Anlin Hao, et al. · Biomedicine & Pharmacotherapy · 13
PDF
Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501)
2022 · You-Sheng Mao, Shu-Geng Gao, et al. · Annals of Translational Medicine · 7
PDF
Real‐World Efficacy and Safety of Sintilimab‐Based Regimens against Advanced Esophageal Cancer: A Single‐Center Retrospective Observational Study
2022 · Chenyu Wang, Linzhi Jin, et al. · BioMed Research International · 6
PDF
Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial
2022 · Bo Yang, Xiaofeng Guo, et al. · BioMed Research International · 5
PDF
Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
2022 · Chenyu Wang, Xinyu Cheng, et al. · BioMed Research International · 4
PDF
Lymph Node Metastasis for pN + Superficial Esophageal Squamous Cell Carcinoma
2025 · Yafan Yang, Liyan Xue, et al. · Thoracic Cancer · 3
PDF
Identification of crucial long non-coding RNAs and mRNAs along with related regulatory networks through microarray analysis in esophageal carcinoma
2021 · Yaowen Zhang, Huitao Wang, et al. · Functional & Integrative Genomics · 3
Three-field vs two-field lymphadenectomy in thoracic ESCC patients: a multicenter randomized study (NST 1503)
2025 · Yousheng Mao, Shuoyan Liu, et al. · Journal of the National Cancer Center · 2
Impact of hospital volume on outcomes of esophagectomy for esophageal cancer: analysis of a prospective multicenter database
2025 · You-sheng Mao, Shu-geng Gao, et al. · Surgical Endoscopy
Anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.
2022 · Yan-Feng Zhang, An-Lin Hao, et al. · Journal of Clinical Oncology
长链非编码rna Snhg3在食管鳞状细胞癌中的表达及其对eca-109细胞迁移和侵袭的影响
2020 · 郭晓锋, Guo Xiaofeng, et al.
Works count: 16
Citation count: 404
H-index: 7
I10-index: 6
Year
Topic
Type